Clinical Trials
13 trialsNCT07416318 2026-02-18
Unveiling the Protein Expression Patterns in Oral Lichen Planus and Leukoplakia Through Comparative Salivary Proteomics
Kocaeli University
Completed
NCT03692325 2024-10-01
Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
Dana-Farber Cancer Institute
Phase 2 Completed
NCT06469892 2024-06-24
Saliva and Plasma Exosomes for Oral Leukoplakia Malignant Transformation Diagnosis and Oral Cancer Prognosis Monitoring
Beijing Stomatological Hospital, Capital Medical University
Completed
NCT05730855 2023-09-13
Diagnostic Accuracy of lncRNA DQ786243 and miRNA146a in Saliva of Oral Potentially Malignant Lesions
Fayoum University
Completed
NCT04712929 2021-01-20
Candida Associated Cytokines in Oral Leukoplakia
All India Institute of Medical Sciences
Completed
NCT00299195 2020-11-19
A Randomized Study of Sulindac in Oral Premalignant Lesions
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT03682562 2020-07-15
Diagnostic Accuracy of Salivary DNA Integrity Index in Oral Malignant and Premalignant Lesions
Cairo University
Completed
NCT04153266 2020-04-02
ODIN-Q
University College, London
Completed
NCT04267419 2020-02-13
Malondialdehyde and Nitrous Oxide as Salivary Biomarkers for Different Oral Lesions
Beni-Suef University
Completed
NCT03031899 2018-11-05
Comparison or Rose Bengal and Toluidine Blue Staining for Lesion Detection Efficacy
The Oxford Dental College, Hospital and Research Center, Bangalore, India
Completed
NCT00453336 2017-02-08
Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract
University of Miami
Phase 2 Completed
NCT00101335 2013-07-11
Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia
Fox Chase Cancer Center
Phase 2 Completed
NCT00155337 2012-12-21
Photodynamic Therapy for Oral Leukoplakia and Erythroleukoplakia
National Taiwan University Hospital
Phase 4 Completed